1 May 2012AmericasPablo Fuentes

A step forward: new dosage patents in Mexico?

In Mexico, as in most of the IP systems around the world, pharmaceutical patents can be obtained to protect novel drug molecules; intermediate compounds thereof; processes for manufacturing such molecules and intermediates; compositions containing them; and uses of the new molecules in a specific therapeutic way. Likewise, new pharmaceutical formulations, new methods of preparation, new crystalline forms, and new therapeutic uses of already known molecules are also available for protection.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
14 May 2026   Isomorphic Labs said the funding round, led by venture firm Thrive Capital, would be used to further its drug design engine and support hiring targets.
Americas
14 May 2026   The agreement is the latest in a string of major deals between Hengrui and multinational drugmakers, and will see the parties jointly develop assets while licensing others.
Americas
13 May 2026   PureWick claims that two rivals infringed its external catheter and urine-management technology in their medical devices.